Ketamine Combined With Psychotherapy as a Treatment for Resistant Depression in a Public European Hospital.
Brain and Behavior 2026 Filipa Alves Da Silva, Rita Avelar, Bernardo Peixoto et al.
Depression affects around 280 million people worldwide, and about 30% of patients have treatment-resistant depression. Ketamine has significant scientific evidence supporting its use as an antidepressant, making it a promising approach for treatment-resistant cases. Combining ketamine with psychotherapy may enhance therapeutic response and support longer-lasting cognitive and behavioral change....
DOI: 10.1002/brb3.71164 (opens in new tab)
Full text (opens in new tab)
Off‐label ketamine
Psychedelic‐assisted therapy
Psychotherapy
Resistant depression
+2